91.29
price down icon0.46%   -0.42
pre-market  プレマーケット:  91.16   -0.13   -0.14%
loading
前日終値:
$91.71
開ける:
$91.92
24時間の取引高:
11.70M
Relative Volume:
1.23
時価総額:
$135.38B
収益:
$19.35B
当期純損益:
$2.78B
株価収益率:
48.83
EPS:
1.8696
ネットキャッシュフロー:
$3.82B
1週間 パフォーマンス:
+1.40%
1か月 パフォーマンス:
-5.33%
6か月 パフォーマンス:
-11.51%
1年 パフォーマンス:
-8.99%
1日の値動き範囲:
Value
$90.92
$93.06
1週間の範囲:
Value
$87.03
$93.06
52週間の値動き範囲:
Value
$85.98
$109.50

Boston Scientific Corp Stock (BSX) Company Profile

Name
名前
Boston Scientific Corp
Name
セクター
Healthcare (1114)
Name
電話
508-683-4000
Name
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Name
職員
53,000
Name
Twitter
@bostonsci
Name
次回の収益日
2025-10-22
Name
最新のSEC提出書
Name
BSX's Discussions on Twitter

BSX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Medical Devices icon
BSX
Boston Scientific Corp
91.29 136.01B 19.35B 2.78B 3.82B 1.8696
Medical Devices icon
ABT
Abbott Laboratories
108.61 209.93B 43.84B 13.90B 6.92B 7.9725
Medical Devices icon
SYK
Stryker Corp
358.67 138.80B 24.38B 2.94B 4.07B 7.6159
Medical Devices icon
MDT
Medtronic Plc
101.34 128.57B 34.76B 4.79B 5.21B 3.7017
Medical Devices icon
EW
Edwards Lifesciences Corp
84.44 49.41B 5.88B 1.34B 799.60M 2.3489

Boston Scientific Corp Stock (BSX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-10-03 ダウングレード Erste Group Buy → Hold
2025-09-08 アップグレード Oppenheimer Perform → Outperform
2025-06-16 開始されました Leerink Partners Outperform
2025-04-16 アップグレード Needham Hold → Buy
2025-01-10 アップグレード Deutsche Bank Hold → Buy
2024-10-18 ダウングレード Needham Buy → Hold
2024-05-30 開始されました Goldman Buy
2024-02-01 アップグレード Mizuho Neutral → Buy
2023-07-19 開始されました Robert W. Baird Outperform
2023-06-30 開始されました CL King Buy
2023-05-30 再開されました Morgan Stanley Overweight
2023-03-29 開始されました UBS Buy
2022-12-22 開始されました Mizuho Neutral
2022-12-20 再開されました Citigroup Buy
2022-10-18 開始されました Barclays Overweight
2022-10-12 開始されました Jefferies Buy
2022-07-06 開始されました Wolfe Research Outperform
2022-05-27 アップグレード Needham Hold → Buy
2022-04-13 再開されました Truist Buy
2022-03-02 再開されました BofA Securities Buy
2021-12-10 開始されました RBC Capital Mkts Outperform
2021-05-26 ダウングレード Needham Buy → Hold
2021-05-25 開始されました Barclays Overweight
2021-04-15 開始されました Atlantic Equities Overweight
2020-09-17 開始されました Truist Buy
2020-09-11 開始されました Wolfe Research Peer Perform
2020-04-22 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-04-01 アップグレード Goldman Neutral → Buy
2020-03-05 開始されました Citigroup Buy
2020-02-13 開始されました Goldman Neutral
2020-02-06 再開されました BTIG Research Buy
2019-12-30 繰り返されました Cowen Outperform
2019-12-19 ダウングレード Needham Strong Buy → Buy
2019-09-05 再開されました JP Morgan Overweight
2019-09-03 再開されました Barclays Overweight
2019-05-13 アップグレード Evercore ISI In-line → Outperform
2018-11-28 開始されました UBS Buy
2018-10-16 開始されました Barclays Overweight
2018-10-02 繰り返されました Morgan Stanley Overweight
2018-09-07 繰り返されました Needham Strong Buy
2018-09-04 アップグレード Jefferies Hold → Buy
2018-07-06 繰り返されました Needham Strong Buy
2018-06-27 開始されました Bernstein Outperform
2018-04-26 繰り返されました Needham Strong Buy
すべてを表示

Boston Scientific Corp (BSX) 最新ニュース

pulisher
05:04 AM

iA Global Asset Management Inc. Acquires 31,717 Shares of Boston Scientific Corporation $BSX - MarketBeat

05:04 AM
pulisher
03:13 AM

Boston Scientific Corporation (NYSE:BSX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat

03:13 AM
pulisher
Jan 22, 2026

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and ACADIA Pharmaceuticals (ACAD) - The Globe and Mail

Jan 22, 2026
pulisher
Jan 22, 2026

Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific’s (BSX) Mew Market Dominance - Insider Monkey

Jan 22, 2026
pulisher
Jan 22, 2026

Oppenheimer Questions $14.5B Penumbra Deal Valuation Despite Boston Scientific's (BSX) Mew Market Dominance - Finviz

Jan 22, 2026
pulisher
Jan 22, 2026

A Closer Look at Boston Scientific's Options Market Dynamics - Benzinga

Jan 22, 2026
pulisher
Jan 22, 2026

Boston Scientific Corporation (NYSE:BSX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance

Jan 22, 2026
pulisher
Jan 22, 2026

Boston Scientific to acquire Alameda-based Penumbra for $14.5 billion - MSN

Jan 22, 2026
pulisher
Jan 21, 2026

Boston Sci secures CE mark for Embold system - BioWorld MedTech

Jan 21, 2026
pulisher
Jan 21, 2026

Boston Scientific Advises Removal Of Certain AXIOS Stents After Deployment Issues Surface - Benzinga

Jan 21, 2026
pulisher
Jan 21, 2026

Universal Beteiligungs und Servicegesellschaft mbH Reduces Holdings in Boston Scientific Corporation $BSX - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

Investors Purchase Large Volume of Call Options on Boston Scientific (NYSE:BSX) - MarketBeat

Jan 20, 2026
pulisher
Jan 20, 2026

Boston Scientific stock rises as BSX teases new pain-therapy data while FDA stent alert hangs over shares - TechStock²

Jan 20, 2026
pulisher
Jan 20, 2026

Boston Scientific has a potentially serious Axios stent recall - MassDevice

Jan 20, 2026
pulisher
Jan 20, 2026

Boston Scientific stock rating reiterated at Outperform by Mizuho - Investing.com

Jan 20, 2026
pulisher
Jan 20, 2026

Boston Scientific recalls stent over issue linked to 3 deaths - MedTech Dive

Jan 20, 2026
pulisher
Jan 20, 2026

3 takeaways from Boston Scientific’s $14.5B Penumbra deal - MedTech Dive

Jan 20, 2026
pulisher
Jan 20, 2026

Boston Scientific to Acquire Alameda-Based Penumbra for $14.5 Billion - alamedapost.com

Jan 20, 2026
pulisher
Jan 20, 2026

Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX) - The Globe and Mail

Jan 20, 2026
pulisher
Jan 20, 2026

Canaccord Genuity downgrades Penumbra stock to Hold after Boston Scientific deal - Investing.com

Jan 20, 2026
pulisher
Jan 19, 2026

Penumbra shares soar pre-market — what is the Boston Scientific agreement? - MSN

Jan 19, 2026
pulisher
Jan 19, 2026

Boston Scientific to Acquire Penumbra - Diagnostic and Interventional Cardiology

Jan 19, 2026
pulisher
Jan 19, 2026

Boston Scientific’s Strategic Acquisition Tests Investor Resolve - AD HOC NEWS

Jan 19, 2026
pulisher
Jan 19, 2026

Synthetic Absorbable Sutures Market Size to Hit USD 4.36 Billion by 2033, Driven by Rising Surgical Volumes and Minimally Invasive Procedures – SNS Insider - GlobeNewswire Inc.

Jan 19, 2026
pulisher
Jan 19, 2026

Allstate Corp Has $5.31 Million Stake in Boston Scientific Corporation $BSX - MarketBeat

Jan 19, 2026
pulisher
Jan 19, 2026

Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio - Today's Medical Developments

Jan 19, 2026
pulisher
Jan 18, 2026

Penumbra Shares Soar Pre-MarketWhat Is The Boston Scientific Agreement? - Menafn

Jan 18, 2026
pulisher
Jan 18, 2026

UnitedHealth Stock Slips Amid Medicare Investigation; Boston Scientific to Acquire Penumbra for $14.5B - Intellectia AI

Jan 18, 2026
pulisher
Jan 18, 2026

Is Boston Scientific Corporation (NYSE:BSX) Worth US$88.1 Based On Its Intrinsic Value? - Yahoo Finance

Jan 18, 2026
pulisher
Jan 18, 2026

Boston Scientific (BSX) Expands Urology Portfolio with Valencia Deal, Analysts Emphasize Organic Growth - Insider Monkey

Jan 18, 2026
pulisher
Jan 18, 2026

Sen. Markwayne Mullin Purchases Shares of Boston Scientific Corporation (NYSE:BSX) - MarketBeat

Jan 18, 2026
pulisher
Jan 17, 2026

A big acquisition decades ago almost broke Boston Scientific. Its CEO says this time is different. - Star Tribune

Jan 17, 2026
pulisher
Jan 17, 2026

Boston Scientific to acquire Penumbra (NYSE: PEN) in $14.5B deal - Stock Titan

Jan 17, 2026
pulisher
Jan 17, 2026

Med tech company Boston Scientific readies for new Austin offices - MSN

Jan 17, 2026
pulisher
Jan 17, 2026

RTW Biotech Opp.Boston Scientific to acquire Penumbra - Research Tree

Jan 17, 2026
pulisher
Jan 16, 2026

Boston Scientific (BSX) stock falls again as traders digest $14.5 billion Penumbra buy - TechStock²

Jan 16, 2026
pulisher
Jan 16, 2026

Penumbra Inc. to be Sold to Boston Scientific for $374 per Share - Intellectia AI

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific to buy Penumbra in $14.5 billion deal - AOL.com

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific (BSX): Oppenheimer Adjusts Price Target, Maint - GuruFocus

Jan 16, 2026
pulisher
Jan 16, 2026

This is Why Wall Street Firms are Bullish on Boston Scientific Corporation (BSX) - Finviz

Jan 16, 2026
pulisher
Jan 16, 2026

Down 6.3% in 4 Weeks, Here's Why Boston Scientific (BSX) Looks Ripe for a Turnaround - Finviz

Jan 16, 2026
pulisher
Jan 16, 2026

Truist Securities reiterates Buy rating on Boston Scientific stock - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific looks to nearly double size of Minnesota facility - MassDevice

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific (NYSE:BSX) Price Target Lowered to $100.00 at Oppenheimer - MarketBeat

Jan 16, 2026
pulisher
Jan 16, 2026

Oppenheimer Adjusts Price Target on Boston Scientific to $100 From $125, Maintains Outperform Rating - marketscreener.com

Jan 16, 2026
pulisher
Jan 16, 2026

Penumbra shares jump as Boston Scientific agrees to $14.5 billion takeover - MSN

Jan 16, 2026
pulisher
Jan 16, 2026

Leerink Partners downgrades Penumbra stock following Boston Scientific deal - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

RTW Biotech Opportunities Portfolio Company Penumbra To Be Acquired By Boston Scientific - DirectorsTalk Interviews

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific to acquire Penumbra for $14.5 billion - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Truist Securities downgrades Penumbra stock to Hold following Boston Scientific acquisition - Investing.com

Jan 16, 2026
pulisher
Jan 16, 2026

Boston Scientific Target of Unusually High Options Trading (NYSE:BSX) - MarketBeat

Jan 16, 2026

Boston Scientific Corp (BSX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
medical_devices SYK
$358.67
price down icon 1.18%
medical_devices MDT
$101.34
price up icon 1.05%
medical_devices ABT
$108.61
price down icon 10.04%
medical_devices EW
$84.44
price down icon 0.82%
$81.89
price up icon 0.97%
大文字化:     |  ボリューム (24 時間):